MRNA vs XPEL · rev $145.0M vs P/E 24, rev $260.4M
Moderna Inc (MRNA) versus Xpel Inc (XPEL) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Xpel Inc (XPEL) is a auto parts company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported XPEL revenue for 2026-06-30 was $260.4M. Net income was $28.4M. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
MRNA currently screens at market cap $24.52B. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
Not investment advice. Open the MRNA and XPEL stock pages for the full models.
Not investment advice.